Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remission

scientific article published on November 15, 1993

Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remission is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/1097-0142(19931115)72:10<2950::AID-CNCR2820721015>3.0.CO;2-B
P953full work available at URLhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819931115%2972%3A10%3C2950%3A%3AAID-CNCR2820721015%3E3.0.CO%3B2-B
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19931115)72:10%3C2950::AID-CNCR2820721015%3E3.0.CO;2-B
https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19931115)72:10%3C2950::AID-CNCR2820721015%3E3.0.CO;2-B
P698PubMed publication ID7693325

P2093author name stringS. Pierce
E. Anaissie
M. J. Keating
M. Beran
S. O'Brien
L. Robertson
E. Estey
H. M. Kantarjian
P2860cites workNonparametric Estimation from Incomplete ObservationsQ25938997
Cancer chemotherapy reportsQ27710278
Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapyQ34560161
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung CancerQ40746556
Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemiaQ40766706
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urotheliumQ40785644
Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemiaQ40805621
Prognostic factors for Stage IV Hodgkin's disease treated with MOPP, with or without bleomycinQ45229426
Acceleration of neutrophilic granulocyte recovery after bone-marrow transplantation by administration of recombinant human granulocyte colony-stimulating factor.Q45996225
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphomaQ46138485
Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemiaQ48300032
A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969.Q54382751
A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesQ56428666
Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationQ63446345
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as Adjunct Therapy in Relapsed Hodgkin DiseaseQ67719984
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancerQ67989066
Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemiaQ68514600
Dose intensity of MOPP chemotherapy and survival in Hodgkin's diseaseQ69386550
Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's diseaseQ69484546
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppressionQ70201925
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectacute lymphocytic leukemiaQ180664
lymphocyteQ715347
P304page(s)2950-2955
P577publication date1993-11-01
1993-11-15
P1433published inCancerQ326041
P1476titleGranulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remission
P478volume72

Reverse relations

cites work (P2860)
Q41634907A comparative review of colony-stimulating factors
Q73127004Adult acute leukemia
Q35024453Colony-stimulating factors for the management of neutropenia in cancer patients
Q43599735Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia
Q58414487Growth factors in the treatment of acute lymphoblastic leukemia
Q43909452High-dose cytarabine-containing chemotherapy with or without granulocyte colony-stimulating factor for children with acute leukemia
Q40631353Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group.
Q48263650Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.
Q36405044Role of cytokines in the treatment of acute leukemias: a review
Q35605280Surgical wound healing using hemostatic gauze scaffold loaded with nanoparticles containing sustained-release granulocyte colony-stimulating factor
Q36177546Sustained-release G-CSF microspheres using a novel solid-in-oil-in-oil-in-water emulsion method